跳至主要内容
临床试验/NCT00446758
NCT00446758已完成3 期

Trial of Zinc and HIV Progression in Children

Harvard School of Public Health (HSPH)1 个研究点 分布在 1 个国家目标入组 440 人开始时间: 2008年3月1日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
440
试验地点
1
主要终点
Morbidity from respiratory and diarrheal infections, HIV disease progression

研究概览

简要总结

To examine whether daily oral zinc supplementation to HIV-infected Tanzanian preschool children reduces diarrheal and respiratory morbidity, delays HIV disease progression, and improves growth.

详细描述

The purpose of this study is to examine whether daily oral zinc supplementation to HIV-infected Tanzanian preschool children reduces diarrheal and respiratory morbidity, delays HIV disease progression, and improves growth.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
6 Weeks 至 60 Months(Child)
性别
All
接受健康志愿者

入选标准

  • HIV Infected Children under 60 months of age presenting at HIV treatment clinics in Dar es Salaam, Tanzania

排除标准

  • Eligible for ART: CD4 cell counts < 20% or above pediatric clinical stage of HIV disease 3 according to WHO staging system.
  • Severe acute malnutrition; Major congenital malformations

结局指标

主要结局

Morbidity from respiratory and diarrheal infections, HIV disease progression

时间窗: every 4 to 6 months until the end of follow-up

次要结局

  • growth in height and weight(every 4 to 6 months until the end of follow-up)

研究者

发起方
Harvard School of Public Health (HSPH)
申办方类型
Other
责任方
Principal Investigator
主要研究者

Eduardo Villamor

Adjunct Associate Professor of International Nutrition

Harvard School of Public Health (HSPH)

研究点 (1)

Loading locations...

相似试验